Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
492
datasets available to search
ShareScore release 0.9.0
Dataset results
492 results for “EGFR mutations;”
A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations
ClinicalTrials.gov study NCT05163028. IPD Sharing: NO. Countries: 2. Publications: 0.
PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker Discovery
ClinicalTrials.gov study NCT02804776. IPD Sharing: NO. Countries: 1. Publications: 0.
BBP-398 in Combination With Osimertinib in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutations
ClinicalTrials.gov study NCT06032936. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations
ClinicalTrials.gov study NCT03082300. IPD Sharing: NO. Countries: 1. Publications: 0.
An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain Metastasis
ClinicalTrials.gov study NCT06352502. IPD Sharing: NO. Countries: 1. Publications: 0.
Feasibility of the Research for Mutation of K-ras and EGFR in CTCs From Metastatic Non Small Cells Bronchial Carcinomas
ClinicalTrials.gov study NCT01380795. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR-Sensitive Mutations Combined With Co-Mutations Advanced NSCLC
ClinicalTrials.gov study NCT06348927. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Furmonertinib and Cisplatin/Pemetrexed as in EGFR Mutated Stage IIIA-IIIB Resectable NSCLC (FORESEE)
ClinicalTrials.gov study NCT05430802. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of DBPR112 in Patients With Head and Neck Cancer and EGFR Mutated Lung Cancer
ClinicalTrials.gov study NCT03246854. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Prevalence of EGFR Mutations in Participants With NSCLC
ClinicalTrials.gov study NCT02695849. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Correlation Between EGFR Mutation Using cfDNAs and Circulating Tumor Cells in Patients With NSCLC
ClinicalTrials.gov study NCT02422628. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer Patients
ClinicalTrials.gov study NCT06071013. IPD Sharing: Not stated. Countries: 1. Publications: 0.
To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation
ClinicalTrials.gov study NCT05555212. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT06525246. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
ClinicalTrials.gov study NCT06706076. IPD Sharing: UNDECIDED. Countries: 9. Publications: 0.
Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations
ClinicalTrials.gov study NCT06517953. IPD Sharing: YES. Countries: 1. Publications: 0.
Osimertinib Plus Bevacizumab in Untreated EGFR Exon21 L858R Mutated NSCLC
ClinicalTrials.gov study NCT04988607. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06755684. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment
ClinicalTrials.gov study NCT00752076. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neratinib Tablets in the Treatment of Advanced NSCLC With Rare EGFR Mutations
ClinicalTrials.gov study NCT06029816. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.